NRSN Neurosense Therapeutics Ltd
Company Analysis
Latest News
🟢 Neurosense Therapeutics Ltd is trading 5.3% up today after securing a new patent in South Korea for its ALS drug candidate
Neurosense Therapeutics Ltd is trading 5.3% up at $0.77 in pre-market after the company announced it has been granted a patent in South Korea for its lead ALS...
🔴 Neurosense Therapeutics Ltd is trading 5.1% down today as it consolidates following a recent patent-driven rally
Neurosense Therapeutics Ltd is trading at $0.72 (down 5.1%) as the stock undergoes consolidation following a significant price jump earlier this week. • The...
🟢 Neurosense Therapeutics Ltd is trading 6.6% up today after securing a patent for its ALS candidate PrimeC in Japan
Neurosense Therapeutics Ltd is trading at $0.81 (6.6%) up today, extending momentum from the prior session after the company announced it was granted a patent...
🟢 Neurosense Therapeutics Ltd is trading 5.8% up today after Japan grants patent for ALS drug PrimeC
Neurosense Therapeutics Ltd is trading 5.8% up at $0.80 today after the company announced that Japan has granted a patent for its lead ALS drug candidate,...
🟢 Neurosense Therapeutics Ltd is trading 10.4% up on Japanese Patent Grant for its ALS drug PrimeC
Neurosense Therapeutics Ltd is trading 10.4% up at $0.83 in pre-market action after the company announced a key patent grant in Japan. * The Japan Patent...
🟢 Neurosense Therapeutics Ltd is trading 8% up today in a relief rally following a multi-session slide
Neurosense Therapeutics Ltd is trading 8% up at $0.81 in a relief rally following a multi-session slide and broader risk-off pressure on small-cap biotech...
🔴 Neurosense Therapeutics Ltd is trading 5.1% down today amid broad market sell-off
Neurosense Therapeutics Ltd is trading 5.1% down at $0.74 as a sharp risk-off move in the broader markets pressures small-cap biotech names. • The decline...